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Introduction
Digital epidemiology, also referred to as digital disease detection (DDD), is motivated by the
same objectives as traditional epidemiology. However, DDD focuses on electronic data sources
that emerged with the advent of information technology [1–3]. It draws on developments such
as the widespread availability of Internet access, the explosive growth in mobile devices, and
online sharing platforms, which constantly generate vast amounts of data containing health-
related information, even though they are not always collected with public health as an objec-
tive. Furthermore, this novel approach builds on the idea that information relevant to public
health is now increasingly generated directly by the population through their use of online
services, without their necessarily having engaged with the health care system [4, 5]. By utiliz-
ing global real-time data, DDD promises accelerated disease outbreak detection, and examples
of this enhanced timeliness in detection have already been reported in the literature. The most
recent example is the 2014 Ebola virus outbreak in West Africa [6]. Reports of the emerging
outbreak were detected by digital surveillance channels in advance of official reports. Further-
more, information gleaned by the various datasets can be used for several epidemiological
purposes beyond early detection of disease outbreaks [7, 8], such as the assessment of health
behavior and attitudes [4] and pharmacovigilance [9].
This is a nascent field that is developing rapidly [10]. While changes in the ways in which
epidemiologic information is obtained, analyzed, and disseminated are likely to result in great
social benefits, it is important to recognize and anticipate potential risks and unintended conse-
quences. In this article we identify some of the key ethical challenges associated with DDD
activities and outline a framework for addressing them. We argue that it is important to engage
with these questions while the field is at an early stage of evolution in order to make ethical
awareness integral to its development.
The Context in Which DDDOperates
DDD operates at the intersection of personal information, public health, and information tech-
nologies, and increasingly within the so-called big data environment. Big data lacks a widely
accepted definition. The term has, nevertheless, acquired substantial rhetorical power. We use
it here in the sense of very large, complex, and versatile sets of data that are constantly evolving
in terms of format and velocity [11]. This dynamic environment generates various ethical chal-
lenges that relate not only to the value of health for individuals and societies, but also to
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individual rights and other moral requirements. In order to spell out these challenges and pos-
sible ways of meeting them, it is necessary to take into account the distinctive nature of DDD
and the broader context in which it operates. Generally, these distinct features are linked to the
methods by which data are generated, the purposes for which they are collected and stored, the
kind of information that is inferred by their analysis, and eventually how that information is
translated into practice [12]. More specifically, some of these relevant features include those
outlined below—namely, the steady growth of digital data, the multifaceted character of big
data, and ethical oversight and governance.
The steady growth of digital data
The amount of data that is generated from activities facilitated by the Internet and mobile tech-
nologies is unprecedented. The global number of mobile-cellular subscriptions is close to the
world’s population figures, with a total penetration rate of 96%. The mobile-cellular penetra-
tion rate in developing countries is 89%, and about 40% of the world’s population is connected
to the internet [13]. 82% of the world’s online population uses social media and networks. [14].
More than 40,000 health apps are available, and a new higher-level Internet domain name
“health” is about to be released [15, 16]. Not surprisingly, personal data have recently been
described as a new asset class with the potential to, among other things, transform health care
and global public health [17].
The multifaceted character of big data
Big data cannot be readily grouped into clearly demarcated functional categories. Depending
on how they are queried and combined with other datasets, a given dataset can traverse catego-
ries in unpredictable ways. For example, health data can now be extracted from our purchases
of everyday goods, our social media exchanges, and our web searches. New data analytics con-
stantly change the kinds of outcomes that become possible. They go beyond early identification
of outbreaks and disease patterns to include predictions of the event’s trajectory or likelihood
of reoccurrence [18, 19]. These new possibilities render good data governance, which ensures
their ethical use, all the more complex.
Ethical oversight and governance
Public health surveillance and public health research are governed by national and internation-
al legislation and guidelines. However, many of these norms were developed in response to
very different historical conditions, including technologies that have now been superseded
[20]. Such mechanisms may not be appropriate or effective in addressing the new ethical chal-
lenges posed by DDD, nor the questions that will be raised if DDD is effectively integrated into
standard public health systems. Health research utilizing social media data and other online
datasets has already exerted pressure on existing research governance procedures [21].
Ethical Challenges
Against this background we have identified three clusters of ethical challenges facing DDD that
require consideration (Table 1).
A. Context sensitivity
At the crux of the debate on the ethics of big data lies a familiar, but formidably complex,
question: how can big data be utilized for the common good whilst respecting individual rights
and liberties, such as the right to privacy? What are the acceptable trade-offs between
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individual rights and the common good, and how do we determine the thresholds for such
trade-offs? These ethical concerns and the tensions between them are not new to public health
research and practice, but now they must be addressed in a new context, with the result that
appropriate standards may vary according to the type of big data activity in question.
It is clear that the context of DDD differs in significant ways from other types of big data ac-
tivity concerned with health. DDD has a public health function, aiming ultimately to improve
health at the population level. Public health is a common good from which all individuals bene-
fit and one that is essential to human development and prosperity. There is a clear contrast
here with forms of corporate activity that may use the exact same data (i.e., social networking
data), but for other purposes, such as advertising. The former aims at fostering a public good
(health); the latter at generating a corporate profit. Such differences have important ethical
implications. A context-sensitive understanding of ethical obligations may reveal that some
data uses that may not be acceptable within corporate activity (e.g., user profiling and data
sharing with third parties) may be permissible for public health purposes. Furthermore, societal
obligations to foster the common good of public health may generate duties on corporate data
collectors to make data available for use in DDD.
Pursuing this line of thought, it is arguable that privacy considerations that apply in stan-
dard public health practice will have to be creatively extended and adapted to the case of DDD.
This will result in new standards that relate to data from a diverse range of sources, e.g., self-
tracking, citizen scientists, social networks, volunteers, or other participatory contexts [22, 23].
Such new standards are urgently needed, especially as greater convergence of datasets becomes
possible. An illustration of global activity on this front is the United Nations Global Pulse proj-
ect [24]. This project explores the concept of data philanthropy whereby public–private part-
nerships are formed to share data for the public good. Such so-called data commons, operating
on the basis of clear rules about privacy and codes of conduct, can profoundly affect disease
surveillance and public health research more generally.
Table 1. Mapping the ethical issues in digital disease detection.
Categories Ethical Challenges Speciﬁc Examples Values
Context sensitivity Differentiating between commercial versus public
health uses of data
Is identiﬁcation permitted? Is consent required for




User agreements, terms of service, participatory
epidemiology
Are users protected in all contexts irrespective of
privacy laws that differ according to jurisdiction?
Transparency
Global health issues Are privately collected data open to global public
health uses?
Global justice
Nexus of ethics and
methodology
Robust methodology: algorithm validation,
algorithm recalibration, noise ﬁltering, and
feedback mechanisms
False identiﬁcation of outbreaks and inaccurate
predictions of outbreak trajectory
Risk of harm
Pressure to mobilize public health resources in light
of rapidly spreading unvalidated predictions
Fair use of resources
Data provenance Awareness about public health uses of personal





Best practice standards Is there a shared code of practice amongst all those
working on DDD?
Trustworthiness
Monitoring bodies (policies for ongoing monitoring
and action plans for correction of false results)




Paced integration of DDD to standard surveillance
systems
Are there mechanisms for redressing harms caused
by DDD activities?
Justice
Communication to the public (prevent hype) Management of expectations Common good
doi:10.1371/journal.pcbi.1003904.t001
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Another dimension of context relates to global justice. Historically, new health tools have
been predominantly used to improve the health of inhabitants of the better-off parts of the
world. DDD projects that access global data are often less costly than traditional public health
approaches. They could thus offer a potential breakthrough in early disease detection that would
benefit communities throughout the world [25, 26]. However, this potential brings moral obliga-
tions in its train. This requires not only efforts to detect diseases in poorer parts of the world but
also measures to ensure that the way data are collected and processed respect the rights and in-
terests of people from these diverse regions and communities. This raises difficult questions of
cultural relativity, such as whether standards of privacy can take different forms in relation to
different cultures or whether some minimal core of uniform standards is also justified.
B. Nexus of ethics and methodology
Robust scientific methodology involves the validation of algorithms, an understanding of con-
founding, filtering systems for noisy data, managing biases, the selection of appropriate data
streams, and so on. Some have expressed skepticism about the role that DDD can play in public
health practice given its early state of development [27]. In 2013, when Google Flu Trends
overestimated flu prevalence levels in the US, further concerns were raised about the sensitivity
of this methodology to the digital environments created by users’ behavior—for example, dif-
ferent uses of search terms [28] from those used to develop the initial algorithm or the distort-
ing influence of searches arising from media coverage of the flu [29, 30].
Methodological robustness is an ethical, not just a scientific, requirement. This is not only
because limited resources are wasted on producing defective results or because trust in scientif-
ic findings is undermined by misleading or inaccurate findings. There is a further risk of harm
to individuals, businesses, or communities if they are falsely identified as affected by an infec-
tious disease. The harm can take many forms, including financial losses, such as a tourist region
being falsely identified as the location of a disease outbreak; stigmatization of particular com-
munities, which may adversely affect individual members; and even the infringement of
individual freedoms, such as the freedom of movement of an individual falsely identified as
a carrier of a particular disease.
The issue of data provenance comes within the remit of ethically sound methodology. Cur-
rently published DDD studies and other initiatives have mostly used data that are in the public
domain (e.g., Twitter) or that have been contributed by individuals with their explicit consent
for use in disease surveillance (flunearyou.org). While in principle data in the public domain
are open to being used for public health purposes, what constitutes public domain on the Inter-
net is the subject of lively debate [31]. Especially in the context of data derived from social net-
work interactions, it remains unclear whether users understand in what ways their data can be
used and who may access them [32]. Any DDD project will inevitably have to navigate this
uncertain environment and so must exercise diligence about data provenance and exhibit
transparency about its uses.
C. Bootstrapping legitimacy
Legitimacy concerns the extent to which DDD is actually ethically justified in imposing the
compliance burdens that it does and also the extent to which it is perceived to be ethically justi-
fied. In recent years the concept of “global health security” has been mobilized by international
organizations, nongovernmental organizations, and national governments to strengthen the
legitimacy of systems of disease surveillance both nationally and globally. The idea of human
security has been expanded to include health (protection from infectious diseases and other
health hazards), augmenting state responsibilities to provide appropriate safeguards. The
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revised International Health Regulations [33], which set out a global legal framework for dis-
ease detection and response, are premised on the understanding that in our globalized world
diseases spread rapidly and therefore on the need for the timely notification of any public
health threat of potentially international significance. They also recognize the importance of
information gathering from various sources, including unofficial or informal ones, whilst also
requiring that the validity of such information be verified [34]. This creates a legitimate space
for DDD activities because they are precisely responses to both the accelerated detection and
the global nature of the spread of disease.
However, even if ethical arguments already justify the DDD enterprise, they only serve as
a starting point. DDD will have to build its own legitimacy over time as an integral part of its
approach. This means that the issues under categories A and B have to be constantly engaged
with thorough processes that bootstrap DDD’s legitimacy, so it is continuously self-generating
and enhanced over time. So, for example, it is not enough simply to appeal to the great contri-
bution that DDD stands to make to the common good of public health. It is important that this
contribution is made in certain ways rather than others, through transparent procedures that
are worthy of engendering trust among those individuals whose data are used in DDD.
Current regulatory and ethical oversight mechanisms are ill-equipped to address the entire
spectrum of DDD-type activities. The distinction between public health and public health
research has long been considered a problematic one, and this is even more evident in the
DDD context. Consider an analogy with participant-led biomedical research—a growing
movement of people collecting data about themselves and conducting various forms of re-
search in large groups. Either such activities fall through the cracks of the existing oversight
mechanisms or else, if they do not, those mechanisms impose inappropriate burdens upon
them [35, 36]. Participatory approaches to disease surveillance confront similar challenges.
Individuals report on disease symptoms on online platforms, (e.g., flunearyou.org) which en-
ables them to contribute to the common good of disease surveillance and often to receive feed-
back about disease prevalence in their area [37]. This active participation potentially empowers
individuals and democratizes the process of scientific discovery. However, data (personally
identifiable information, geolocation, etc.) that are collected for DDD purposes need to be gov-
erned in ways that minimize the risk of harm to participants. For example, if individuals take
personal risks in order to report events of public health importance (i.e., a farmer reporting
avian flu at risk of losing his flock), those risks should be mitigated by appropriate policies
(e.g., compensation) that acknowledge the societal contribution and the local/personal costs.
For the purposes of ensuring its legitimacy, DDDmust develop internal mechanisms such
as its own best-practice standards, including monitoring boards with the concrete mandate to
ensure that risks and costs to individuals and communities are proportional to benefits. Such
boards should also be empowered to negotiate compensation schemes for harms that have
been suffered. As in standard public health practice individuals may be adversely affected by
a practice that aims to secure the health of the population. However, this laudable goal does
not remove the obligation to respect individual rights and dignity in its pursuit. Neither of
these standards are to be equated with an automatic insistence on individual consent. Instead,
they consist of distinct individual entitlements, of the sort set out in the Universal Declaration
of Human Rights, and the inherent value in all human beings, which underlies them.
Conclusions
The emergence of DDD promises tangible global public health benefits, but these are accompa-
nied by significant ethical challenges. While some of the challenges are inherent to public
health practice and are only accentuated by the use of digital tools, others are specific to this
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approach and largely unprecedented. They span a wide spectrum, ranging from risks to indi-
vidual rights, such as privacy and concerns about autonomy, to individuals’ obligations to
contribute to the common good and the demands of transparency and trust. We have grouped
these concerns under the headings of context sensitivity, nexus of ethics and methodology, and
bootstrapping legitimacy. It is vital that engagement with these challenges comes to be seen as
part of the development of DDD itself, not as some extrinsic constraint. We intend this paper
to be a contribution to the development of a more comprehensive and concrete ethical frame-
work for DDD, one that will enable DDD to find an ethical pathway to realizing its great poten-
tial for public health.
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